Pfiz­er sets up Bind auc­tion with $20M stalk­ing horse bid

Pfiz­er has stepped in to help with Bind Ther­a­peu­tics’ as­set sale, set­ting a stalk­ing horse bid for its as­sets at $20 mil­lion. That ba­si­cal­ly sets the floor on the price as Bind – once a promis­ing nan­otech com­pa­ny found­ed by MIT’s Robert Langer – looks to get the best price from an auc­tion.

That auc­tion should now pro­ceed on Ju­ly 25th, with Bind $BIND look­ing to wrap up the sale some­time in the third quar­ter.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.